Cargando…
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380506/ https://www.ncbi.nlm.nih.gov/pubmed/28275957 http://dx.doi.org/10.1007/s13300-017-0246-7 |
_version_ | 1782519780740169728 |
---|---|
author | Kalra, Sanjay |
author_facet | Kalra, Sanjay |
author_sort | Kalra, Sanjay |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5380506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-53805062017-04-17 Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes Kalra, Sanjay Diabetes Ther Erratum Springer Healthcare 2017-03-08 2017-04 /pmc/articles/PMC5380506/ /pubmed/28275957 http://dx.doi.org/10.1007/s13300-017-0246-7 Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Erratum Kalra, Sanjay Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes |
title | Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes |
title_full | Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes |
title_fullStr | Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes |
title_full_unstemmed | Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes |
title_short | Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes |
title_sort | erratum to: auxiliendo, primum non nocere: a preliminary view of the devote trial comparing cardiovascular safety of insulin degludec versus insulin glargine in type 2 diabetes |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380506/ https://www.ncbi.nlm.nih.gov/pubmed/28275957 http://dx.doi.org/10.1007/s13300-017-0246-7 |
work_keys_str_mv | AT kalrasanjay erratumtoauxiliendoprimumnonnocereapreliminaryviewofthedevotetrialcomparingcardiovascularsafetyofinsulindegludecversusinsulinglargineintype2diabetes |